Drug interactions
Anagrelide + Ponesimod
Severity: Major
Anagrelide and Ponesimod: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Ponesimod slows heart rate and can affect conduction, and anagrelide can prolong QT, so the combination may raise arrhythmia risk, particularly with bradycardia. The concern is greatest in patients with existing heart disease.
What this interaction means in plain words
Anagrelide and Ponesimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Anagrelide belongs to Cardiovascular; Ponesimod belongs to Central Nervous System.
Why it happens
Additive effects: ponesimod-induced bradycardia increases vulnerability to anagrelide-related QT prolongation.
What to do
Obtain an ECG before starting ponesimod and seek cardiology advice if QT-prolonging drugs are required. Monitor heart rate and QTc after initiation.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Anagrelide and Ponesimod, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Anagrelide
- Anagrelide + Panobinostat Contraindicated
- Anagrelide + Pimozide Contraindicated
- Anagrelide + Thioridazine Contraindicated
- Anagrelide + Vandetanib Contraindicated
- Abrocitinib + Anagrelide Major
- Alfuzosin + Anagrelide Major
Other interactions of Ponesimod
- Fingolimod + Ponesimod Contraindicated
- Ponesimod + Siponimod Contraindicated
- Amiodarone + Ponesimod Major
- Amisulpride + Ponesimod Major
- Anti-thymocyte + Ponesimod Major
- Asenapine + Ponesimod Major
Frequently asked questions
Can I take Anagrelide with Ponesimod?
MediHelp rates the interaction as major. Anagrelide and Ponesimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ponesimod slows heart rate and can affect conduction, and anagrelide can prolong QT, so the combination may raise arrhythmia risk, particularly with bradycardia. The concern is greatest in patients with existing heart disease.
How serious is the interaction between Anagrelide and Ponesimod?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain an ECG before starting ponesimod and seek cardiology advice if QT-prolonging drugs are required. Monitor heart rate and QTc after initiation.
What other medicines interact with Anagrelide?
MediHelp also lists interactions of Anagrelide with, for example, Panobinostat, Pimozide, Thioridazine. The full list is on the Anagrelide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
